Table 2.
Pro- and anti-oxidative effects of different GPR55 ligands.
| Compound | Observed effects | |||
|---|---|---|---|---|
| Agonists | Upregulated | Unchanged | Downregulated | Study |
| Anandamide |
NOS2 expression, NO production |
[72] | ||
| AM251 | NOS2 expression | [72] | ||
| O-1602 | NO production | [69, 70] | ||
| SOD, GSH, Catalase | Malondialdehyde | [84, 85] | ||
| SOD activity | Malondialdehyde | [86] | ||
| LPI |
iNOS synthesis, NO production, ROS production |
[69] | ||
| ROS production | [116] | |||
| DHA-DA |
nNOS expression, NO synthesis, ROS production |
eNOS, iNOS | [97] | |
| Antagonists | ||||
| CID-16020046 |
NOS2 expression, NO production |
[72] | ||
| NOX4 expression & synthesis, ROS production | [117] | |||
| Nrf2 | ROS production | [100] | ||
| KIT C, KIT H | Nrf2 | 8-iso-PGF2α production, oxidative cell death | [58] | |